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Although Rap GTPases of the Ras family remained enigmatic 
for years, extensive studies in this decade have revealed di-
verse functions of Rap signaling in the control of cell pro-
liferation, differentiation, survival, adhesion, and movement. 
With the use of gene-engineered mice, we have uncovered 
essential roles of endogenous Rap signaling in normal lym-
phocyte development of both T- and B-lineage cells. Deregu-
lation of Rap signaling, on the other hand, results in the de-
velopment of characteristic leukemia in manners highly de-
pendent on the contexts of cell lineages. These results high-
light crucial roles of Rap signaling in the physiology and path-
ology of lymphocyte development. 
[Immune Network 2009;9(2):35-40]
INTRODUCTION
Among the Ras superfamily G proteins, Rap GTPases (Rap1a, 
1b, Rap2a, 2b, 2c) show the highest overall homology to clas-
sic Ras with an identical effector region (1,2). Rap GTPases 
are activated by a wide variety of external stimuli; the activa-
tion is mediated by specific guanine nucleotide exchange fac-
tors (GEFs), including C3G recruited by receptor protein ty-
rosine kinases, Epacs activated by cyclic AMP, and CalDAG 
GEFs activated by Ca
2＋ and/or diasylglycerol (3). On the oth-
e r ha nd ,  t he  sw ift  in ac t iv at io n o f Ra pG TP  c an  b e ac h ie ve d 
with the aid of specific GTPase-activating proteins (GAPs), in-
cluding Spa-1 family (Spa-1, Spa-L1, 2, 3) and RapGA1 (I, II) 
(3).  In  most  cell  types,  Rap  and  Ras  are  activated  con-
comitantly by many stimuli; however, they are under the dis-
tinct regulatory mechanisms, and Rap signaling may induce 
biological effects quite different from Ras signaling (4,5). In 
lymphocytes, Rap signaling is activated by various stimuli, in-
cluding specific antigens, lymphokines, and chemokines. One 
of the most appreciated biological effects of Rap signaling is 
the regulation of cell adhesion; this effect is in part mediated 
by the activation of integrins (2,6,7). Through this effect, Rap 
signaling induces enhanced cell-matrix and cell-cell adhesion 
a s  w e l l  a s  c e l l  m i g r a t i o n  ( 8 ) .  The  effect  is  mediated  partly 
by a Rap-specific effector called RapL, which associates with 
the intracellular domain of integrin α -units, mediating the in-
side-out activation of integrins on lymphocyte stimulation (9). 
Recent studies, however, indicate that the role of Rap signal-
ing in lymphocytes goes beyond the regulation of cell adhe-
sion and migration, affecting the cell fate decision in many 
cell types in the immune system. In this brief review, I shall 
summarize our recent studies on the crucial roles of Rap sig-
naling  in  normal  lymphocyte  development  as  well  as  the 
disorders.
ESSENTIAL ROLE OF RAP SIGNALING IN NORMAL 
LYMPHOCYTE DEVELOPMENT
Rap  family  consists  of  several  highly  related  members  with 
substantial functional redundancy, and this has been a major 
complication of the functional studies of Rap signaling. Re-
cently, Rap1a-/- and Rap1b-/- mice were generated; however, 
they revealed surprisingly mild phenotypes (10,11). The re-
sults  present  a  stark  contrast  with  early  embryonic  lethality 
of C3G-/- as well as Spa-1 transgenic (Tg) mice, underscoring 
the functional redundancy among the Rap family members. 
To overcome the problem, we have investigated the role of 
Rap  signaling  in  normal  lymphocyte  development  with  the 
use  of  conditional  Tg  mice  for  Spa-1  or  dominant-negative Rap Signaling in Normal Lymphocyte Development and Leukemia Genesis
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Rap mutant (Rap1A17) capable of inhibiting the activation of 
all  Rap  family  members  in  a  physiological  setting  (12).
T-lineage cell development
Conditional expression of Spa-1 in T-lineage cells (lck-Spa-1 
Tg mice) resulted in a profound defect of thymic α β  T cell 
development without affecting γ δ  T cells (13). The thymic 
CD4/CD8 double-positive (DP) T cells were markedly dimin-
ished  due  to  the  arrested  transition  from  double-negative 
(DN) stage 3 (CD25
＋ CD44
－) to DN stage 4 (CD25
－ CD44
－), 
corresponding to β -selection checkpoint. In β -selection che-
ckpoint,  the  thymocytes  that  have  successfully  rearranged 
TCRβ  g e n e s  a n d  e x p r e s s e d  p r e - T C R  a r e  r e s c u e d  f r o m  c e l l  
death followed by the robust expansion via Notch-signaling, 
whereas those that have failed to do so are doomed to die 
via p53-dependent pathway (14,15). DN stage 4 thymocytes 
in the lck-Spa-1 Tg mice revealed a markedly enhanced apop-
tosis in situ, suggesting that Rap signaling was crucial for the 
rescue  of  pre-T  cells  from  cell  death.  Indeed,  it  was  con-
firmed that the ligand-independent, autonomous pre-TCR sig-
naling activated both Rap1 and Rap2 in a DN thymocyte cell 
line.  Furthermore,  forced  expression  of  farnesylated,  con-
stitutive  active  C3G  (C3G-F)  in  Rag2-/-  thymocytes  induced 
their  significant  expansion  in  the  presence  of  Notch-ligand 
(Delta-like  1)-expressing  stroma  cells,  bypassing  pre-TCR. 
And finally, it was found that lck-Spa-1 Tg mice at the p53-/- 
genetic background showed completely normal development 
of α β  T cells; the effect of p53 was gene dosage-dependent 
in that lck-Spa-1 p53+/- mice revealed a partial restoration of 
DP thymocyte development. These results unambiguously in-
dicate that Rap signaling is essential in the rescue of pre-T 
cells from p53-mediated cell death in β -selection checkpoint. 
Currently, it remains unknown how the p53 checkpoint path-
way usually associated with DNA damages is activated during 
pre-T cell development, and it also remains to be investigated 
how Rap signaling downstream of pre-TCR interferes with the 
p53-mediated cell death. We have confirmed that essentially 
identical  phenotypes  are  found  in  lck-Rap1A17  Tg  mice 
(Wakae,  K  and  Minato,  N,  unpublished  observation). 
Importantly,  CD4-Spa-1  Tg  mice  showed  normal α β  T  c e l l 
development, indicating that Rap signaling is dispensable for   
α β   TCR-mediated  positive  selection  (Fig.  1).
B-lineage cell development
We also investigated the effects of Rap signaling in B cell de-
velopment with the use of mb1-Rap1A17 Tg mice, which con-
ditionally expressed a dominant-negative Rap1A17 mutant in 
B-lineage  cells. The  mb.1-Rap1A17 mice showed a marked 
diminution of BM pre-B cells, which exhibited impaired sur-
vival and expansion in response  to  IL-7  despite  normal  IL- 
7Rα  expression (Katayama, Y et al., submitted for publicati-
on).  The  IL-7  responsiveness  could  not  be  restored  by  the 
expression  of  either  constitutive  active  (CA)  Stat5a o r  C A - 
PI3K-p100; thus, the defect could be not attributable to the 
proximal signaling downstream of IL-7R. The results are con-
sistent  with  the  finding  that  lck-Spa-1  and  lck-Rap1A17  Tg 
mice show completely normal γ δ T cell development, which 
is absolutely dependent on IL-7 (13). It is shown that an ap-
propriate level of E2A, a bHLH transcription factor, is crucial 
for the competence of IL-7 response in pre-B cells (16). Thus 
E2A+/- mice reveal a significantly diminished development of 
pre-B  cells,  while  E2A-/-  mice  show  a  complete  defect  in 
B-cell development (17). This effect is in part mediated by 
myc (c-myc and N-myc) proteins (16), which provide an es-
sential  driving  force  for  the  IL-7-mediated  survival  and  ex-
pansion  of  B-lineage  progenitors  (BLP).  We found  that the 
mb.1-Rap1A17 mice showed a significantly reduced expres-
sion of E2A gene, and the impaired IL-7 responsiveness was 
restored  by  the  transduction  of  c-myc  gene.  The  results 
strongly  suggest  that  Rap  signaling  plays  an  important  role 
in sustaining the appropriate level of E2A in pre-B cells suffi-
cient for the competence of IL-7 response. Accordingly, the 
mb.1-Rap1A17 mice showed markedly decreased mainstream 
B  cells  in  the  peripheral  tissues  with  reduced  numbers  of 
follicles. However, the residual follicular B cells proliferated 
normally in response to the BCR stimulation and showed an 
efficient germinal center reaction following antigen immuni-
zation. Thus, Rap signaling plays a crucial role in pre-B cell 
development as well, whereas it is largely dispensable for the 
functioning  of  mature  B  cells  in  vivo  (Fig.  1).
DEREGULATED RAP SIGNALING AND LEUKEMIA
While the potential oncogenic effect of Rap signaling was a 
matter  of  arguments,  the  effect  has  been  first  revealed  in 
Spa-1-targeted mice in vivo. Thus, Spa-1-/- mice developed 
a wide spectrum of leukemia with long latent periods, includ-
ing  myeloid,  B-lineage  and  infrequently  T-lineage  leukemia 
(18). Because Spa-1is a principal Rap GAP in hematopoietic 
progenitors  (HPC)  (19),  such  leukemia  genesis  is  attributed 
to the constitutive activation of endogenous Rap signaling in 
HPC. Given the crucial roles of Rap signaling in normal de-Rap Signaling in Normal Lymphocyte Development and Leukemia Genesis
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Figure 1. Rap signaling plays essential roles in normal lymphocyte development and leukemia genesis. Endogenous Rap signaling in T- and 
B-lineage cells has been conditionally modified by genetic manipulations; it is inhibited by the transgenic expression of SPA-1 or Rap1A17 (blue),
and augmented by SPA-1 KO or C3G-F expression (red). Rap activation downstream of pre- TCR signaling is crucial to rescue the thymic pre-T 
cells with proper expression of TCRβ  chains from p53-dependent cell death, called β -selection checkpoint. On the contrary, constitutive Rap
activation in T-lineage progenitors results in the Notch-mutations and Notch-dependent T-ALL genesis. Rap signaling is also essential for the 
competence of IL-7-mediated survival and proliferation of pre-B cells in the BM. In addition, Rap signaling functions as a “self-sensing signal”
in the immature B cells of BM to initiate B cell receptor (BCR) editing. The deregulated activation of Rap results in the acute B-CLL in collaboration
with the loss-of function of p53 or B1-CLL associated with autoantibodies.
velopment of both T- and B-lineage cells, we addressed the 
involvement of deregulated Rap signaling in leukemia gene-
sis. 
Notch-dependent T-cell acute lymphoblastic 
leukemia (T- ALL)
T  cell  leukemia  was  observed  only  infrequently  in  Spa-1-/- 
mice; however, it might well be due to the expression of oth-
er Spa-1 family genes (Spa-Ls) in the thymocytes compensat-
ing  Spa-1.  We  therefore  investigated  the  effects  of  deregu-
lated endogenous Rap activation alternatively by the forced 
expression of C3G-F. Transplantation of the HPC retrovirally 
transduced with C3G-F into lethally irradiated mice resulted 
in marked thymic hyperplasia, consisting of blastic DP cells. 
These thymocytes were of oligoclonal origin, being reminis-
c e n t  o f  m u l t i c e n t r i c  t h y m o m a  ( 2 0 ) .  T h e  t h y m i c  h y p e r p l a s i a 
was more striking when Spa-1-/- HPC transduced with C3G-F 
were transplanted: around half of such recipients developed 
l e t h a l  s y s t e m i c  T  c e l l  l e u k e m i a  i n v a d i n g  m o s t  v i t a l  o r g a n s  
within 3 months (20). These leukemic cells were highly blas-Rap Signaling in Normal Lymphocyte Development and Leukemia Genesis
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tic DP cells of monoclonal origin, being compatible with the 
diagnosis of T cell acute lymphoblastic leukemia (T-ALL). The 
difference  in  the  disease  phenotypes,  thymoma  vs.  T-ALL, 
paralleled  with  the  extents  of  endogenous  Rap  activation; 
thus C3G-F
＋ Spa-1-/- HPC-derived T-ALL cells showed much 
higher RapGTP levels than C3G-F
＋ B6 HPC-derived thymoma 
cells.  Interestingly,  T-ALL  cells  so  generated  from  C3G-F
＋ 
Spa-1-/- HPC all exhibited very high levels of an active form 
of Notch (1 and 3) along with the enhanced expression of 
Notch target genes such as Hes1, pTα , c-myc, and cyclin D1. 
Furthermore, their continuous proliferation in vitro was com-
pletely inhibited by a γ -secretase inhibitor, indicating the de-
pendence of the leukemic growth on Notch signaling (20). 
The generation of Notch-dependent T-ALL was independent 
of pre-TCR, in agreement with the view that excessive Rap 
signaling  synergized  with  Notch,  bypassing  pre-TCR  signal 
(21,22).  Accumulating  evidence  reveals  a  crucial  role  of 
Notch in human T-ALL. Although previously discovered Tan1, 
an active Notch IC via chromosomal translocation, is a rather 
rare event, recent studies indicate that the majority of human 
T-ALL show characteristic mutations in Notch gene at the two 
hot spots: HD (heterodimerization domain) and the PEST re-
gion  containing  a  protein  degradation  target  site  (22).  Also 
in murine models, T-ALLs developed in Scl-Tg and Ikaros-/- 
mice  revealed  Notch  mutations  at  very  high  frequencies 
(23-25). Indeed, we have found that all the T-ALL cells devel-
oped from C3G-F
＋ Spa-1-/- HPC show insertional mutations 
at the PEST region of Notch gene, leading to the frame shift 
and  premature  termination  (20).  Importantly,  all  the  muta-
tions result in the loss of Thr residue at position 2512, a cru-
cial phospholylation site for the recognition of an E3 ligase 
FBW7 affecting Notch (26). The reason why Notch gene mu-
tations are induced in the thymocytes with excessive Rap acti-
vation  remains  to  be  investigated,  and  it  also  remains  un-
known  whether  the  mutations  are  restricted  to  Notch  gene 
or not. Nonetheless, these results provide the first indication 
that  the  deregulated  small  G  protein  signaling  can  be  in-
volved  in  T-ALL  genesis  (Fig.  1).
B-cell leukemia and autoimmunity
A l t h o u g h  t h e  m a jo r i t y  o f  l e u k e m i a  i n  S p a - 1 - / -  m i c e  w a s  o f 
myeloid origin, a significant proportion (around 15%) of them 
developed chronic B-lineage cell leukemia. Interestingly, the 
leukemic cells were non-blastic lymphoid cells exhibiting CD5 
and  Mac1  expression,  apparently  corresponding  to  B1  cells 
(27).  Indeed,  the  majority  of  Spa-1-/-  mice  showed  a  pro-
gressive increase in the peritoneal B1 cell population preced-
ing overt leukemia development; this was associated with the 
generation  of  anti-dsDNA  antibody  and  lupus-like  glomer-
ulonephritis (27). It has been shown that the excessive Rap 
activation downstream of BCR signaling on immature BM B 
cells  enhances  the  secondary  Igκ   gene  rearrangement  and 
expression via p38MAPK/Creb-mediated OcaB induction, that 
is,  BCR-receptor  editing.  Given  that  the  receptor  editing  in 
the potentially autoreactive immature B cells is crucial to ab-
r o g a t e  t h e  a u t o r e a c t i v i t y ,  i t  i s  s u g g e s t e d  t h a t  R a p  s i g n a l i n g  
may  function  as  a  "self-sensing"  signal  that  initiates  the  re-
ceptor editing upon encounter with self antigens. It is sug-
gested  that  deregulated  Rap  signaling  in  such  B  cells  of 
Spa-1-/- mice results in the excessive receptor editing, causing 
the accumulation of B1 cells with aberrant receptor editing 
and even Igκ /λ  isotypic inclusion retaining the autoreactivity. 
In  agreement, many  of  the  Spa-1-/- mice  with B1  cell-type 
leukemia also showed a hemolytic autoantibody, reminiscent 
of human B cell chronic lymphocytic leukemia (CLL) (Fig. 1). 
Interestingly, E2A+/- mice show the defective secondary IgL 
gene rearrangement and expression leading to the impaired 
r ec e pt or  ed it in g  ( 17 ),  t hu s it  ma y be  po ss ib le  t ha t a be rr an t 
E2A expression may also contribute to the excessive receptor 
editing in Spa-1-/- immature B cells. Most recently, we have 
found that Spa-1-/- mice are hypersensitive to X-ray radiation, 
and that their HPC reveal an enhanced p53 expression, imply-
ing the continuous genostresses (H. Tanaka and N. Minato, 
manuscript in preparation). In agreement with the findings, 
Spa-1-/- p53-/- mice rapidly develop acute leukemia at much 
shorter latent periods than Spa-1-/- mice, including highly ag-
gressive T-lineage and B-lineage acute lymphoblastic leuke-
mia (T, B-ALL) with gross chromosomal anomalies. (H. Tana-
ka and N. Minato, manuscript in preparation). Thus, exces-
sive Rap signaling can highly predispose the malignant trans-
formation  of  lymphoid  cells,  rapidly  inducing  acute  blastic 
leukemia when combined with the loss-of-function of tumor 
s u p p r e s s o r  g e n e s  ( F i g .  1 ) .
CONCLUSION
Because of their structural similarity to Ras, the possible in-
volvement of Rap in oncogenesis has been investigated ex-
tensively (28). Although it is unlikely that Rap functions as 
a classic oncogene that bypasses the various growth factors 
like classical Ras, a series of our genetic studies revealed cru-
cial roles of Rap signaling in a wide variety of leukemia. Our Rap Signaling in Normal Lymphocyte Development and Leukemia Genesis
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recent studies, on the other hand, indicate that Rap signaling 
is crucially involved in normal development of both T- and 
B-lineage cells. Therefore, it seems quite likely that the de-
regulated Rap signaling contributes to the leukemogenesis as 
direct  consequences  of  the  disturbed  lymphocyte  develop-
ment. The  molecular mechanisms of  leukemia genesis may 
v a r y  d e p e n d i n g  o n  t h e  c o n t e x t s  o f  c e l l - l i n e a g e s  a n d  d e v e l-
opmental stages, including the interaction with cell type-spe-
cific  factors.  Our  recent  results  further  suggest  the  involve-
ment of excessive Rap signaling in the genetic instability of 
lymphocytes. In human leukemia, the involvement of classi-
cal Ras mutations is a relatively rare event, and thus further 
analysis on Rap signaling in leukemia may provide a new in-
sight  into  the  leukemia  genesis  in  humans.
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